A new report shows that the new open enrollment rules are leading to increased Medicare Advantage uptake.
A new report from eHealth shows that there is still significant consumer interest in Medicare Advantage plans.
eHealth, an online health insurance exchange that allows members to compare insurance plans, recently surveyed 579 individuals who purchased a Medicare insurance plan through their website during the new open enrollment period for Medicare Advantage plans.
According to Chris Hakim, senior vice president and general manager, Medicare for eHealth, the study was conducted to analyze the recently reintroduced and updated open enrollment period. That period, was discontinued in 2011, but was rebirthed this year and went from January 1 to March 31. Under the new system, members are allowed to change from one Medicare Advantage plan to another if their previous plan didn’t satisfy their coverage needs.
Overall, eHealth received 87% more Medicare Advantage and Part D plan applications than the previous year.
“Our report illustrates strong consumer interest in Medicare Advantage and Part D plans at eHealth, despite the fact that relatively few consumers were aware of the new open enrollment period, which wasn’t broadly publicized,” says Hakim.
Related: Medicare Advantage Members Spend Less Than Traditional Medicare Members
Of the enrollees surveyed by eHealth, half (51%) were previously unaware of the open enrollment period.
The report also shows a decrease in Medicare Advantage plan premiums. Average monthly premiums dropped by 33% between 2018 and 2019, from $12 to $8. Out-of-pocket limits also decreased by an average of 11%.
Enrollees also gave their rationale for switching plans. About half of the switches were due to unhappiness with a previous insurer, costs, or provider network. Twenty-two percent said they were dissatisfied with their former insurance company, while 12% switched because they said their preferred doctor was now out of network.
“Our report illustrates continued strong consumer interest in Medicare Advantage plans,” says Hakim. “These plans are receiving additional support from government in an increasingly innovative and competitive market, and are expected to become a bigger part of the total Medicare landscape in the United States.”
Nicholas Hamm is an editor with Managed Healthcare Executive
Phase 3 Trial of Vertex’s Islet Cell Therapy for Type 1 Diabetes in Under Way
April 23rd 2025Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if approved, would be the second cell therapy for type 1 diabetes.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Experts Explore Causes and Care for Chronic Itch
April 22nd 2025In a recent discussion with Managed Healthcare Executive, three leading dermatologists and itch experts—Shawn Kwatra, M.D., Brian Kim, M.D., and Gil Yosipovitch, M.D.—shared where the science is going, what’s holding it back and how the healthcare system can better support patients.
Read More